The Role of Exercise Training in the Treatment of Resistant Hypertension
NCT ID: NCT03090529
Last Updated: 2020-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-03-30
2020-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise group
The 12-week exercise-training program will include three sessions of aerobic exercise per week
Exercise Group
The 12-week exercise-training program will include three sessions of aerobic exercise per week
Control group
The control group will receive usual medical care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Group
The 12-week exercise-training program will include three sessions of aerobic exercise per week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
2. Evidence of target organ damage
3. Patients with heart failure
4. Previous cardiovascular event
5. Peripheral artery disease
6. Renal failure
7. Chronic obstructive pulmonary disease
8. Systolic office blood pressure superior to 180 mmHg
9. Biomechanical limitations to physical activity
10. Those participating in regular physical activity
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Institute of Maia
OTHER
Cardiology Department, Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga
UNKNOWN
Hypertension and Cardiovascular Unit, Hospital Pedro Hispano, ULS Matosinhos
UNKNOWN
Cintesis & Departamento de Medicina da Faculdade de Medicina do Porto
UNKNOWN
Aveiro University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fernando Ribeiro
Adjunct Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José Mesquita Bastos, MD, PhD
Role: STUDY_DIRECTOR
Hospital Infante D. Pedro, Centro Hospitalar Do Baixo Vouga
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology Department, Hospital Infante D. Pedro, Centro Hospitalar do Baixo Vouga
Aveiro, , Portugal
Hypertension and Cardiovascular Unit, Hospital Pedro Hispano, ULS Matosinhos
Matosinhos Municipality, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lopes S, Mesquita-Bastos J, Garcia C, Bertoquini S, Ribau V, Teixeira M, Ribeiro IP, Melo JB, Oliveira J, Figueiredo D, Guimaraes GV, Pescatello LS, Polonia J, Alves AJ, Ribeiro F. Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension: A Randomized Clinical Trial. JAMA Cardiol. 2021 Nov 1;6(11):1317-1323. doi: 10.1001/jamacardio.2021.2735.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1725/2014
Identifier Type: -
Identifier Source: org_study_id